STAGE IV RENAL CELL CANCER AJCC V7
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a pill stop kidney Cancer's return after surgery?
Disease control OngoingThis study tests whether the drug pazopanib can delay or prevent kidney cancer from returning in people who have had surgery to remove all visible tumors. About 129 adults with advanced kidney cancer that spread to other parts of the body but was fully removed by surgery will tak…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:39 UTC
-
Experimental combo aims to starve cancer cells in Late-Stage tumors
Disease control OngoingThis early-phase trial tests the safety and best dose of two drugs—MK-2206 and hydroxychloroquine—given together to people with advanced solid tumors, melanoma, prostate, or kidney cancer. The goal is to see if blocking a process called autophagy can help kill more cancer cells. …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Inhaled immune booster shows promise for lung metastases
Disease control OngoingThis study tests an inhaled form of a natural immune protein (IL-2) to treat cancers that have spread to the lungs, such as melanoma, kidney cancer, and sarcoma. About 70 adults will receive the drug through a nebulizer to see what dose is safe and whether it can shrink lung tumo…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC